Second line treatment options for pancreatic cancer.

about

Second line treatment options for pancreatic cancer.

Item

http://www.wikidata.org/entity/Q38640398

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Second line treatment options for pancreatic cancer.

@en

type

Item

label

Second line treatment options for pancreatic cancer.

@en

prefLabel

Second line treatment options for pancreatic cancer.

@en

P1476

Second line treatment options for pancreatic cancer.

@en

P2093

Frank C Passero

http://www.w3.org/2001/XMLSchema#string

Muhammad Wasif Saif

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.

Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

P31

scholarly article

P356

10.1080/14656566.2017.1369955

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28820270

http://www.w3.org/2001/XMLSchema#string

Second line treatment options for pancreatic cancer.

about

Second line treatment options for pancreatic cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698